摘要
3月4—6日,2023年美国心脏病学年会(ACC 2023)在美国新奥尔良市召开。结构性心脏病领域的多项临床研究揭晓了新进展。本文就主动脉瓣Evolut Low Risk 3年随访结果、二尖瓣COAPT试验5年结果、UK Mini Mitral试验和STS/ACC TVT注册研究,三尖瓣TRILUMINATE Pivotal研究等作一简要介绍。
On March 4-6,ACC 2023 was held in New Orleans,US.Several clinical studies in the field of structural heart disease have revealed new progress.Here,we present a brief review on 3-year follow-up results of Evolute Low Risk in aortic valve stenosis,COAPT 5-year follow-up results,UK Mini Mitral and STS/ACC TVT Registry Analysis in mitral regurgitation,and TRILUMINATE Pivotal in tricuspid regurgitation.
作者
林吉斌
程翔
LIN Jibin;CHENG Xiang(Department of Cardiology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,430022,China;Hubei Key Laboratory of Biological Targeted Therapy,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology;Hubei Engineering Research Center for Immunological Diagnosis and Therapy of Cardiovascular Diseases,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology)
出处
《临床心血管病杂志》
CAS
北大核心
2023年第4期263-264,269,共3页
Journal of Clinical Cardiology
关键词
结构性心脏病
经导管主动脉瓣置换术
经导管缘对缘修复
structural heart disease
transcatheter aortic valve replacement
transcatheter edge to edge repair
